ArthritoMab Arthritis-Inducing Antibody Cocktail. For the induction of arthritis in the Collagen Antibody Induced Arthritis (CAIA) model: a shorter, more synchronized alternative to the classic CIA model.
Ovalbumin-Induced Asthma. Suitable efficacy models to aid in the discovery of novel treatments.
Experimental Allergic Encephalomyelitis (EAE). A myelin mediated disease model for the study of Multiple Sclerosis.
Peripheral Nerve Injury Models of Neuropathic Pain. Understanding the mechanisms underlying neuropathic pain syndromes is crucial to the development of more effective therapies.
A new animal model of Post-operative Pain. An optimal model for assessment of analgesic effect of various local treatment strategies such as implants, patches, medical devices and creams.
In vitro biomarker assay development for companion animal research.
Applications e-Newsletter for preclinical drug development within inflammatory and neurological diseases.
Discovery of novel therapies for rheumatodi diseases & asssociated pain requires suitable and relevant disease models. A comparison of monoarthritis and polyarthritis disease models.
Discovery of Novel therapies for asthma requires suitable and relevant disease models.
Monoclonal Antibody-Induced Arthritis: a shorter, more synchronized alternative to the classic CIA model.
Asthma: Measuring the breadth of new medicines.